Dose Adjustments In The Senscis Trial Of Nintedanib In Patients With Systemic Sclerosis-Associated Ild (Ssc-Ild)M. Kreuter,K. B. Highland,M. Kuwana,A. Azuma,T. Maher,M. D. Mayes,G. Raghu,M. Girard,V Kohlbrenner,E. Clerisme-Beaty,M. Alves,O. DistlerEUROPEAN RESPIRATORY JOURNAL(2020)引用 1|浏览22暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要